Skip to main content
UniHealth

Doctor search

Amitabh Kant Bharadwaj, MD

Ophthalmology · Pinole

NPI 1477511806

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
8
1 carrier
Offices
2
Since medical school
25 years
Harvard Medical School, 2001

Offices

2 locations

Looking this up.

Hospitals listed: Alta Bates Summit Medical Center - Alta Bates Camp · California Pacific Medical Center- Van Ness Campus. That is not proof they admit you there this week.

Plans that list them

8 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bharadwaj’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026

California Medical Board record

Licence A101201 · Current

Licensed to practise in California · since 2007 · expires 2028-11-30 · Harvard Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Ophthalmology - Ophthalmology

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
  • California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend it
    Overall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp

Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Alta Bates Summit Medical Center - Alta Bates Camp
Clostridium Difficile (C.Diff)Infections0.298BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.18 (0.16 to 2.2) · 730 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.87 (0.51 to 1.23)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths188.12 (132.31 to 243.94) · 50 casesNo differentJul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths6.8 · 50 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.8 · 41 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.4 · 189 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths12.6 · 184 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 103 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.9 · 1,585 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.18 (0 to 0.4) · 3,929 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.31 (0.11 to 0.51) · 3,954 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.15 (0.95 to 5.36) · 754 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.62 (0 to 3.33) · 325 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.99 (0.39 to 3.59) · 717 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths10.85 (2.27 to 19.44) · 326 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.79 (1.08 to 8.49) · 302 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.68 (0.19 to 3.18) · 184 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.17 (0 to 0.88) · 3,240 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.4 · 161 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.207No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.48No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.785No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.4 · 243 casesNoneJul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-58.2 · 194 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-12.3 · 177 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 209 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.4 (3.8 to 7.5) · 215 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.2 (9.4 to 15.5) · 215 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits4.8 · 150 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.2 · 81 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.4 (10 to 18.1) · 315 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.6 to 1.2) · 137 casesNo differentJan 2024 – Dec 2024

What patients said (449 patients answered, 15% of those asked)

Patient survey stars by topic at Alta Bates Summit Medical Center - Alta Bates Camp
Cleanliness2
Nurse communication2
Doctor communication2
Communication about medicines2
Discharge information2
Overall hospital rating2
Quietness2
Recommend hospital3
Share of patients giving the best answer at Alta Bates Summit Medical Center - Alta Bates Camp
Room was "always" clean62%
Nurses "always" communicated well72%
Doctors "always" communicated well75%
Staff "always" explained53%
Yes, staff "did" give patients this information82%
Yes, staff "did" give patients information about help after discharge82%
Doctors "always" explained things so they could understand68%
Doctors "always" listened carefully73%
Doctors "always" treated them with courtesy and respect83%
Patients who gave a rating of "9" or "10" (high)58%
Staff "always" explained new medications67%
Nurses "always" explained things so they could understand67%
Nurses "always" listened carefully66%
Nurses "always" treated them with courtesy and respect81%
"Always" quiet at night49%
"YES", patients would definitely recommend the hospital67%
Staff "always" explained possible side effects38%
Yes, staff "did" give patients information about possible symptoms83%
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at California Pacific Medical Center- Van Ness Campus
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.224BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.325BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.373BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.14 (0.3 to 1.97) · 2,271 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.05 (0.81 to 1.28)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths192.86 (151.51 to 234.22) · 140 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.6 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths10.3 · 60 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.5 · 143 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.8 · 356 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.3 · 259 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 173 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.1 · 2,316 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.31 (0.12 to 0.49) · 6,430 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.09 to 0.47) · 7,168 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.3 (1.5 to 5.09) · 2,196 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2.47 (1.21 to 3.74) · 925 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.63 (1.37 to 3.88) · 1,954 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths10.13 (6.06 to 14.2) · 1,112 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths7.26 (4.67 to 9.85) · 1,084 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.67 (0.31 to 3.03) · 832 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.33 (0 to 0.85) · 5,406 casesNo differentJul 2022 – Jun 2024
MRSA BacteremiaInfections0.443No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.717No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.3 · 200 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22.3 · 449 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits18.2 · 187 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits8.7 · 418 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits7.1 · 260 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits19.2 · 293 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (3.6 to 7.6) · 157 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.2 (7.7 to 13.5) · 157 casesNo differentJan 2024 – Dec 2024
Rate of readmission for CABGUnplanned return visits11 · 33 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.2 · 66 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.5 (9.4 to 16.7) · 551 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.3) · 219 casesNo differentJan 2024 – Dec 2024

What patients said (478 patients answered, 20% of those asked)

Patient survey stars by topic at California Pacific Medical Center- Van Ness Campus
Cleanliness4
Nurse communication3
Doctor communication3
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness3
Recommend hospital5
Share of patients giving the best answer at California Pacific Medical Center- Van Ness Campus
Room was "always" clean75%
Nurses "always" communicated well74%
Doctors "always" communicated well77%
Staff "always" explained59%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand71%
Doctors "always" listened carefully75%
Doctors "always" treated them with courtesy and respect85%
Patients who gave a rating of "9" or "10" (high)75%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand70%
Nurses "always" listened carefully71%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital78%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms88%

Original Medicare doctor bills

$1,831,459

Medicare paid this office $1,831,459 for 621 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Injection, aflibercept, 1 mg146$1,092,426None
Injection, aflibercept hd, 1 mg24$199,300None
Injection of drug into eye208$135,162$120
Injection, faricimab-svoa, 0.1 mg11$74,976None
Imaging of retina608$73,223$40
See all 14 services
Every Original Medicare service billed
Injection, aflibercept, 1 mg146$1,092,426None
Injection, aflibercept hd, 1 mg24$199,300None
Injection of drug into eye208$135,162$120
Injection, faricimab-svoa, 0.1 mg11$74,976None
Imaging of retina608$73,223$40
Unclassified biologics13$65,712None
Established patient problem focused exam of visual system388$58,538$88
Injection, bevacizumab, 10 mg54$16,660None
Established patient complete exam of visual system121$15,543$120
New patient complete exam of visual system105$14,591$139
Removal of eye fluid (vitreous) between lens and retina12$9,825$819
New patient visit (45+ min)63$9,771$155
New patient visit (60+ min)32$6,631$207
Photography of the retina11$405$37

Procedures Medicare counted

Procedure volume Medicare published
Cataract surgery1-10None

Procedures year by year

Procedures billed to Original Medicare by year
Procedure201920202021202220232024
Injection of drug into eye5114817069228361,123
Photocoagulation treatment to prevent detachment of retina–––17––
Removal of eye fluid (vitreous) between lens and retina–––––12

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

621 Original Medicare patients in 2024. Average age 78 · Under 65 2% · 85 and older 22% · Women 59% · Also on Medicaid 16% · Health risk score 1.29. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.

Conditions among them: High blood pressure 70% · Diabetes 27% · Coronary heart disease 21% · Chronic kidney disease 21% · Cancer 18% · Atrial fibrillation 17% · Depression 16% · Heart failure 12% · COPD 10% · Stroke 8% · Dementia 7%.

The office billed $5,083,530, Medicare allowed $2,304,036 and paid $1,831,459; for 9,681 services of 39 kinds; $1,407,085 of it was for drugs given in the office and $424,374 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20246219,681781.29$5,083,530$1,831,459
20235188,118771.24$3,088,288$1,151,541
20225065,867761.17$2,805,096$1,164,241
20214083,791751.19$1,822,085$880,288
20202982,490741.26$1,097,750$541,059
20193082,684741.39$1,166,055$546,591
20182051,600751.43$411,200$179,773
2017106814711.69$176,705$69,747
201687770711.28$167,025$64,869
201535232711.78$55,095$21,969
201414211731.75$49,400$19,193

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 10 services

Original Medicare services billed in 2023
Injection, aflibercept, 1 mg100$727,809None
Injection of drug into eye161$96,425$115
Imaging of retina508$55,339$39
Established patient problem focused exam of visual system289$41,260$87
New patient complete exam of visual system139$19,554$141
Injection, bevacizumab, 10 mg60$16,925None
Established patient complete exam of visual system86$10,697$123
New patient visit (45+ min)36$5,415$150
New patient visit (60+ min)20$4,070$204
2d ultrasound scan of eye tissue and structures13$853$47

2022: 11 services

Original Medicare services billed in 2022
Injection, aflibercept, 1 mg89$837,651None
Injection of drug into eye160$99,286$108
Imaging of retina478$54,486$36
Established patient problem focused exam of visual system281$35,220$76
Injection, bevacizumab, 10 mg89$21,576None
New patient complete exam of visual system167$21,186$127
Established patient complete exam of visual system74$8,920$119
New patient visit (45+ min)32$4,668$146
Photocoagulation treatment to prevent detachment of retina14$3,895$229
New patient visit (60+ min)12$2,437$203
Photography of the retina11$404$37

2021: 7 services

Original Medicare services billed in 2021
Injection, aflibercept, 1 mg82$660,046None
Injection of drug into eye132$76,101$108
Imaging of retina391$44,169$37
Established patient problem focused exam of visual system219$29,615$78
New patient complete exam of visual system177$21,611$122
Injection, bevacizumab, 10 mg76$17,381None
Established patient complete exam of visual system27$3,357$120

2020: 6 services

Original Medicare services billed in 2020
Injection, aflibercept, 1 mg50$391,951None
Injection of drug into eye97$43,680$91
Imaging of retina292$28,477$36
Established patient problem focused exam of visual system167$19,161$72
New patient complete exam of visual system123$15,265$124
Injection, bevacizumab, 10 mg56$12,223None

2019: 8 services

Original Medicare services billed in 2019
Injection, aflibercept, 1 mg49$354,056None
Injection of drug into eye84$45,795$90
Imaging of retina297$31,073$37
Established patient problem focused exam of visual system158$24,787$77
New patient complete exam of visual system169$21,302$126
Injection, bevacizumab, 10 mg60$14,034None
Established patient complete exam of visual system29$3,417$110
Exam of the internal drainage system of eye11$677$25

2018: 8 services

Original Medicare services billed in 2018
Injection, aflibercept, 1 mg11$43,997None
Injection of drug into eye56$23,153$92
Imaging of retina183$19,662$39
Established patient complete exam of visual system95$19,612$110
New patient complete exam of visual system128$17,133$134
Established patient problem focused exam of visual system86$14,634$78
Injection, bevacizumab, 10 mg53$13,049None
Photocoagulation treatment to prevent detachment of retina12$6,864$490

2017: 6 services

Original Medicare services billed in 2017
Established patient complete exam of visual system62$11,615$105
Injection of drug into eye31$11,341$86
Imaging of retina95$7,901$35
Injection, bevacizumab, 10 mg30$7,233None
New patient complete exam of visual system51$6,412$126
Established patient problem focused exam of visual system33$6,059$67

2016: 8 services

Original Medicare services billed in 2016
Established patient complete exam of visual system48$17,534$108
Injection of drug into eye27$9,796$90
Imaging of retina77$7,982$41
New patient complete exam of visual system58$6,754$116
Compounded drug, not otherwise classified26$5,842None
Established patient problem focused exam of visual system25$3,091$77
Exam of retinal blood vessels using a special camera after injection of a dye11$2,115$96
Photography of the retina15$994$66

2015: 4 services

Original Medicare services billed in 2015
Established patient complete exam of visual system18$6,268$110
Injection of drug into eye13$4,176$89
Imaging of retina23$2,422$40
New patient complete exam of visual system16$1,973$123

2014: 1 service

Original Medicare services billed in 2014
Imaging of retina12$1,844$42

Medicaid work

$61,292 in 2024

Medicaid paid $61,292 for 659 billed services this clinician did in 2024, up to 51 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient221$26,196
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina347$17,715
Intravitreal injection of a pharmacologic agent (separate procedure)91$17,381
Medicaid work by year
2024659351$61,292
20231,132665$116,591
20221,198671$147,715
2021864551$60,368
2020478438$23,070
2019773656$43,816
2018611637$39,561
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Intravitreal injection of a pharmacologic agent (separate procedure)230$35,450
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient300$32,896
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina555$24,968
Aflibercept injection13$18,992
OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST15$2,591
Injection, bevacizumab, 10 mg19$1,694

2022

Largest Medicaid services in 2022
Aflibercept injection43$63,915
Intravitreal injection of a pharmacologic agent (separate procedure)235$27,177
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient274$26,011
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina579$24,696
OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST29$4,481
Injection, bevacizumab, 10 mg38$1,435

2021

Largest Medicaid services in 2021
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina494$22,008
Intravitreal injection of a pharmacologic agent (separate procedure)153$16,613
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient156$14,291
OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST33$4,862
Injection, bevacizumab, 10 mg28$2,595

2020

Largest Medicaid services in 2020
Intravitreal injection of a pharmacologic agent (separate procedure)100$8,102
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina290$7,492
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient72$5,752
Injection, bevacizumab, 10 mg16$1,724

2019

Largest Medicaid services in 2019
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient173$13,481
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina411$8,733
Intravitreal injection of a pharmacologic agent (separate procedure)84$8,143
OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST51$7,685
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST27$3,831
Injection, bevacizumab, 10 mg27$1,943

2018

Largest Medicaid services in 2018
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST145$19,563
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina332$7,783
Intravitreal injection of a pharmacologic agent (separate procedure)60$6,226
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient30$2,370
Injection, bevacizumab, 10 mg30$2,250
OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST14$1,369

Drugs they prescribed that Part D paid

$12,130

Pharmacies billed $12,130 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 344) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.

229 generic and 115 brand-name prescriptions · $12,130 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Prednisolone Acetate54$3,491$65
Atropine Sulfate35$2,777$79
Brimonidine19$1,234$65
Ofloxacin72$1,096$15
Dorzolamide-Timolol49$985$20
See all 7 drugs
Every Part D drug this clinician prescribed
Prednisolone Acetate54$3,491$65
Atropine Sulfate35$2,777$79
Brimonidine19$1,234$65
Ofloxacin72$1,096$15
Dorzolamide-Timolol49$985$20
Latanoprost50$198$4
Acetazolamide12$167$14

Year by year

Part D prescribing by year
20243441060% (0)33%$12,130
2023264920% (0)28%$14,034
2022152520% (0)32%$8,833
2021157470% (0)46%$7,842
2020165500% (0)44%$11,665
2019191410% (0)60%$13,134
201877280% (0)62%$6,201
201740110% (0)55%$1,293
201619None0% (0)None$505
201519None0% (0)None$708
201433190% (0)None$765
201319NoneNoneNone$896

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 6 drugs

Part D drugs prescribed in 2023
Prednisolone Acetate38$3,144$83
Atropine Sulfate20$1,742$87
Dorzolamide-Timolol43$1,674$39
Ofloxacin66$1,629$25
Brimonidine21$335$16
Latanoprost27$331$12

2022: 5 drugs

Part D drugs prescribed in 2022
Dorzolamide-Timolol26$1,355$52
Atropine Sulfate20$1,252$63
Prednisolone Acetate27$1,245$46
Ofloxacin17$247$15
Latanoprost13$220$17

2021: 6 drugs

Part D drugs prescribed in 2021
Prednisolone Acetate25$1,855$74
Atropine Sulfate11$1,555$141
Latanoprost30$938$31
Dorzolamide-Timolol16$516$32
Brimonidine17$311$18
Ofloxacin16$226$14

2020: 4 drugs

Part D drugs prescribed in 2020
Prednisolone Acetate36$2,233$62
Dorzolamide-Timolol17$1,024$60
Latanoprost25$562$22
Brimonidine17$269$16

2019: 5 drugs

Part D drugs prescribed in 2019
Prednisolone Acetate38$2,837$75
Brimonidine20$2,566$128
Atropine Sulfate32$2,340$73
Combigan11$1,908$173
Latanoprost30$377$13

2018: 3 drugs

Part D drugs prescribed in 2018
Prednisolone Acetate14$1,407$101
Ketorolac Tromethamine12$609$51
Ofloxacin11$179$16

2014: 2 drugs

Part D drugs prescribed in 2014
Gavilyte-C11$187$17
Ofloxacin11$134$12

Money from drug and device companies

$26 in 2024

Industry payments by year
202411None$26
202311None$17
202222None$63
202022None$32
201911None$23

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Regeneron PharmaceuticalsEylea Hd$26
1 payment
  • Meals for Eylea Hd · 2024-10-11 · $26
See the published payment
Every published payment
Regeneron PharmaceuticalsMeals · 2024-10-11Eylea Hd$26
See earlier years (2023, 2022, 2020, 2019)

2023: $17

Payments by company in 2023
Apellis PharmaceuticalsSyfovre$17
1 payment
  • Meals for Syfovre · 2023-05-10 · $17

2022: $63

Payments by company in 2022
Genentech USAVabysmo$35
1 payment
  • Meals for Vabysmo · 2022-11-17 · $35
AbbvieOzurdex$28
1 payment
  • Meals for Ozurdex · 2022-04-14 · $28

2020: $32

Payments by company in 2020
Carl Zeiss Meditec AGNone Specified$19
1 payment
  • Gift for None Specified · 2020-04-03 · $19
Novartis PharmaceuticalsBeovu$13
1 payment
  • Meals for Beovu · 2020-03-05 · $13

2019: $23

Payments by company in 2019
Novartis PharmaceuticalsNone$23
1 payment
  • Meals · 2019-07-15 · $23

Checkups this office reported

7 measures · 2023

Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.

Medicare’s overall office score
77.3 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Checkup rates this office reported to Medicare
Asked about smokingPatients asked about tobacco, with help to quit if they smoke40%That's less than half.425
Breast cancer screeningEligible women who got a mammogram0%That's few of the people this applied to.24
Diabetes eye examPeople with diabetes who got a retinal eye exam97%That's most of the people this applied to.256
Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high100%That's most of the people this applied to. Worse on this measure.20
Medications listed in the chartVisits where the current medication list was documented50%That's more than half.1,797
Primary Open-Angle Glaucoma (POAG): Optic Nerve EvaluationAs Medicare defines this measure0%65
Risky medications in older adultsOlder patients given a medication that is risky at their age0%That's few of the people this applied to. Better on this measure.610

What the office says it does

Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.

  • Implementation of medication management practice improvements
  • Improved the patient portal
  • Lets patients read their visit notes
  • Uses standard treatment protocols

Professional record

NPI
1477511806
Licence
CA A101201California A101201: Current · expires 2028-11-30
Trained
Harvard Medical School, 2001 · 25 years ago
Gender
Male
More record details
Sole proprietor
Yes
Medicaid ID
NJ 001976049
Taxonomy
Federal specialty code 207W00000X (207W00000X)
Mailing address
1320 Tara Hills Dr Ste H, Pinole, CA, 94564
NPI first listed
2006-05-03
NPI last updated
2013-06-03

This is when the NPI record was last certified, not a medical board exam.